Invesco NASDAQ Biotechnology ETF
IBBQ
21 hedge funds and large institutions have $9.66M invested in Invesco NASDAQ Biotechnology ETF in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
5% less funds holding
Funds holding: 22 → 21 (-1)
5.93% less ownership
Funds ownership: 31.15% → 25.22% (-5.9%)
16% less capital invested
Capital invested by funds: $11.6M → $9.66M (-$1.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$387K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$67.4K |
| 3 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$55.1K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$31.2K |
| 5 |
CGL
Clarius Group LLC
Seattle,
Washington
|
+$1.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$846K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$315K |
| 3 |
PCIG
Partners Capital Investment Group
Boston,
Massachusetts
|
-$298K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$59.4K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9K |
IBBQ Hedge Fund Activity: Q4 2024 in Review
21 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q4 2024, worth a combined $9.66M — down 16% from $11.6M a quarter earlier.
Fund positioning in IBBQ was balanced in Q4 2024: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 4 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $387K. The largest seller was Mirae Asset Global Investments, cutting an estimated $846K.
- 21 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q4 2024, down from 22 in Q3 2024.
- Funds reported $9.66M of Invesco NASDAQ Biotechnology ETF stock for Q4 2024, down 16% quarter-over-quarter.
- 4 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q4 2024 and 4 closed out, a net change of 0 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q4 2024 was Tower Research Capital (TRC), an estimated $387K added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q4 2024 was Mirae Asset Global Investments, an estimated $846K sold.
Based on aggregated 13F filings for Q4 2024.